TABLE 1.
Baseline anthropometrics, plasma lipid, and fasting plasma glucose concentrations in healthy volunteers, according to -11377 C/G, -11391 G/A, 276 G/T, and 45 T/G polymorphisms at the adipoQ gene1,2
| -11377 C > G |
-11391 G > A |
+276 G > T |
+45 T > G |
|||||
|---|---|---|---|---|---|---|---|---|
| C/C | C/G+G/G | G/G | G/A+A/A | G/G | G/T+T/T | T/T | T/G+G/G | |
| n | 34 | 25 | 41 | 18 | 31 | 28 | 45 | 14 |
| Males/females, n | 17/17 | 13/12 | 20/21 | 10/8 | 18/13 | 12/16 | 23/22 | 7/7 |
| BMI, kg/m2 | 21.72 ± 3.29 | 21.00 ± 2.86 | 21.00 ± 3.23 | 22.44 ± 2.48 | 21.87 ± 2.74 | 20.98 ± 3.43 | 21.29 ± 3.14 | 21.85 ± 2.80 |
| Plasma total cholesterol, mmol/L | 4.32 ± 0.61 | 4.01 ± 0.56 | 4.19 ± 0.68 | 4.20 ± 0.45 | 4.25 ± 0.60 | 4.12 ± 0.63 | 4.16 ± 0.60 | 4.31 ± 0.64 |
| Plasma LDL-C, mmol/L | 2.69 ± 0.59 | 2.44 ± 0.48 | 2.57 ± 0.62 | 2.63 ± 0.42 | 2.66 ± 0.54 | 2.51 ± 0.60 | 2.55 ± 0.56 | 2.71 ± 0.55 |
| Plasma HDL-C, mmol/L | 1.27 ± 0.30 | 1.25 ± 0.24 | 1.27 ± 0.31 | 1.25 ± 0.17 | 1.22 ± 0.31 | 1.29 ± 0.23 | 1.27 ± 0.25 | 1.26 ± 0.34 |
| Plasma TG, mmol/L | 0.78 ± 0.33 | 0.69 ± 0.28 | 0.76 ± 0.30 | 0.68 ± 0.32 | 0.78 ± 0.32 | 0.68 ± 0.30 | 0.73 ± 0.29 | 0.74 ± 0.36 |
| Plasma Apo A-1, g/L | 1.51 ± 0.17 | 1.44 ± 0.15 | 1.48 ± 0.17 | 1.48 ± 0.13 | 1.48 ± 0.16 | 1.46 ± 0.14 | 1.47 ± 0.15 | 1.52 ± 0.19 |
| Plasma Apo B, g/L | 0.75 ± 0.11 | 0.70 ± 0.13 | 0.75 ± 0.13 | 0.70 ± 0.13 | 0.74 ± 0.13 | 0.71 ± 0.13 | 0.72 ± 0.12 | 0.75 ± 0.15 |
| Plasma glucose (fasting), mmol/L | 4.85 ± 0.31 | 4.75 ± 0.36 | 4.85 ± 0.34 | 4.76 ± 0.35 | 4.84 ± 0.37 | 4.80 ± 0.33 | 4.83 ± 0.34 | 4.79 ± 0.37 |
Values are means ± SD.
There were no effects of genotype (ANOVA).